Projects funded by the NCN
Proteomic analysis of myeloma plasma cells to determine proteins and pathways involved in acquired resistance to proteasome inhibitors.
2017/25/B/NZ5/01827
Keywords:
proteomics multimple myeloma proteasome inhibitors resistance
Descriptors:
- NZ5_3: Pathogenesis of human diseases
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski
woj. wielkopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 6
Call: OPUS 13 - announced on 2017-03-15
Amount awarded: 1 151 464 PLN
Project start date (Y-m-d): 2018-02-09
Project end date (Y-m-d): 2024-08-08
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.